MICHAEL RAAB - 17 Mar 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Director
Signature
Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
17 Mar 2023
Transactions value $
-$143
Form type
4
Filing time
21 Mar 2023, 19:41:03 UTC
Previous filing
24 Feb 2023
Next filing
25 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $49.8K +15K +30.35% $3.32 64.4K 17 Mar 2023 Direct
transaction FOLD Common Stock Sale -$49.9K -4.41K -6.84% $11.33 60K 17 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -15K -100% $0.00* 0 17 Mar 2023 Common Stock 15K $3.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the options were fully vested and exercisable as of the transaction date.